Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine vs ESPB for Rib Fracture Analgesia
NCT04707183Phase 2Withdrawn
- Sponsor
- Stanford University
- Start
- May 2025
- Primary completion
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Lidocaine Hydrochloride Injection, without epinephrine in rib fracture, sponsored by Stanford University. Planned start May 2025; status: withdrawn.
02
Drugs
Lidocaine Hydrochloride Injection, without epinephrine
03
Conditions
rib fracture
Beyond the preview
Go deeper on NCT04707183.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04707183.